Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-19-129270
Filing Date
2019-04-30
Accepted
2019-04-30 16:05:55
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d741133d10ka.htm 10-K/A 282552
2 EX-31.3 d741133dex313.htm EX-31.3 3416
3 EX-31.4 d741133dex314.htm EX-31.4 3481
  Complete submission text file 0001193125-19-129270.txt   290574
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 19781646
SIC: 2834 Pharmaceutical Preparations